Keyphrases
Locoregional Control
100%
Head-and-neck Cancer
100%
Chemoradiotherapy
100%
Apparent Diffusion Coefficient
64%
FDG PET-CT
50%
Predicting Treatment Response
50%
Shunt Embolization
50%
Gastric Antral Vascular Ectasia
50%
Imaging Biomarkers
50%
Diffusion Magnetic Resonance Imaging (dMRI)
50%
Clinical Outcomes
50%
Magnetic Resonance Imaging
50%
Radiation Treatment Planning
50%
4DCT
50%
Anesthetized Rats
50%
Hypotension
50%
Splenorenal Shunt
50%
Edema
50%
Sodium Nitroprusside
50%
Clinical Target Volume
50%
Cone-beam CT
37%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
36%
Anaphylaxis
35%
Anemia
30%
Multivariate Analysis
26%
Dose Coverage
25%
Organs at Risk
25%
Treatment Planning
25%
Treatment Course
25%
Planning Target Volume
25%
Interobserver Agreement
25%
T2 Relaxation Time
21%
Hypothalamus
21%
Progression-free Survival
20%
Regional Failure
20%
Tumor Location
20%
N Stage
20%
Tumor Regression
20%
Blood Transfusion
20%
Bleeding
20%
Prognostic Value
16%
SUVmax
16%
T Stage
16%
Brain Water Content
14%
Histological Examination
14%
Vasodilator
14%
Mast Cells
14%
Stomach Volume
12%
Respiratory Motion
12%
Target Localization
12%
Medicine and Dentistry
Chemoradiotherapy
100%
Head and Neck Cancer
100%
Biological Marker
50%
Tumor Regression
50%
Positron Emission Tomography-Computed Tomography
50%
Treatment Response
50%
Stomach Antrum Vascular Ectasia
50%
Diffusion MRI
50%
Embolization
50%
Radiation Treatment Planning
50%
Splenorenal Shunt
50%
Volume CT
50%
Mucosa-Associated Lymphoid Tissue
50%
Multivariate Analysis
41%
Progression Free Survival
33%
Head and Neck Squamous Cell Carcinoma
33%
Neoplasm
33%
Treatment Planning
33%
Anemia
30%
Head and Neck Carcinoma
25%
Blood Transfusion
20%
Logistic Regression Analysis
16%
Primary Tumor
16%
Log Rank Test
16%
Univariate Analysis
16%
Gastric Lymphoma
16%
Image Quality
16%
Dose-Volume Histogram
16%
Humoral Antibody
10%
Chronic Kidney Disease
10%
Gastrin
10%
Gastrointestinal Endoscopy
10%
Argon Plasma Coagulation
10%
Bleeding
10%
Pharmacology, Toxicology and Pharmaceutical Science
Head and Neck Cancer
100%
Chemoradiation Therapy
100%
Anaphylaxis
50%
Biological Marker
50%
Nitroprusside Sodium
50%
Hypotension
50%
Edema
50%
Tumor Regression
50%
Polyethylene Terephthalate
50%
Neoplasm
33%
Progression Free Survival
33%
Head and Neck Squamous Cell Carcinoma
33%
Head and Neck Carcinoma
25%
Primary Tumor
16%
Antihypertensive Agent
14%
Vasodilator Agent
14%
Ovalbumin
7%
Sprague Dawley Rat
7%
Larynx Edema
7%
Brain Edema
7%
